Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PALISADE BIO, INC. | 106,952 | reported | 01 Jul 2015 | tx 2+163,844 |
| Rubius Therapeutics, Inc. | 25,000 | reported | 12 May 2022 | tx 6+127,500 |
| Axcella Health Inc. | 20,000 | reported | 19 May 2022 | tx 5+74,000 |
| Jazz Pharmaceuticals plc | 14,868 | reported | 14 Aug 2023 | tx 42+79,792−36,074 |
| Maze Therapeutics, Inc. | 5,805 | reported | 07 Jan 2026 | tx 11+47,413−58,826 |
| Altimmune, Inc. | 1,500 | reported | 05 Jan 2026 | tx 7+176,900 |
| LIFECORE BIOMEDICAL, INC. \DE\ | 0 | reported | 04 Jun 2022 | tx 38+129,645−67,221 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Jan 2026 | SALE | Maze Therapeutics, Inc. | 26,920 | 39.11 USD | anomaly |
| 07 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 3,281 | 10.42 USD | |
| 07 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 2,895 | 10.42 USD | |
| 07 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 20,744 | 10.42 USD | |
| 06 Jan 2026 | SALE | Maze Therapeutics, Inc. | 2,493 | 38.62 USD | |
| 06 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 2,493 | 10.42 USD | |
| 07 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 3,281 | 0.00 USD | deriv |
| 07 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 2,895 | 0.00 USD | deriv |
| 07 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 20,744 | 0.00 USD | deriv |
| 06 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 2,493 | 0.00 USD | deriv |
| 05 Jan 2026 | PURCHASE | Altimmune, Inc. | 500 | 4.24 USD | |
| 25 Sept 2025 | GRANT_AWARD | Altimmune, Inc. | 48,800 | 0.00 USD | deriv |
| 22 Sept 2025 | GRANT_AWARD | Maze Therapeutics, Inc. | 18,000 | 0.00 USD | deriv |
| 17 Mar 2025 | PURCHASE | Altimmune, Inc. | 1,000 | 5.78 USD | first after silence |
| 06 Feb 2025 | GRANT_AWARD | Altimmune, Inc. | 18,600 | 0.00 USD | deriv |
| 26 Sept 2024 | GRANT_AWARD | Altimmune, Inc. | 34,900 | 0.00 USD | deriv |
| 28 Sept 2023 | GRANT_AWARD | Altimmune, Inc. | 26,100 | 0.00 USD | deriv |
| 11 Aug 2023 | GRANT_AWARD | Jazz Pharmaceuticals plc | 3,075 | 0.00 USD | |
| 14 Aug 2023 | SALE | Jazz Pharmaceuticals plc | 1,241 | 138.16 USD | |
| 23 Mar 2023 | GRANT_AWARD | Altimmune, Inc. | 47,000 | 0.00 USD | deriv |
| 05 Aug 2022 | GRANT_AWARD | Jazz Pharmaceuticals plc | 2,561 | 0.00 USD | |
| 08 Aug 2022 | SALE | Jazz Pharmaceuticals plc | 1,089 | 152.32 USD | |
| 04 Jun 2022 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 7,059 | 9.50 USD | |
| 04 Jun 2022 | EXERCISE | LIFECORE BIOMEDICAL, INC. \DE\ | 7,059 | 9.50 USD | deriv |
| 31 May 2022 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 9,474 | — | deriv |
2 purchases reported after at least 12 months of silence — most recent on 17 Mar 2025.